Project Details
Description
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
| Status | Active |
|---|---|
| Effective start/end date | 2/4/25 → 2/3/26 |
Funding
- AARDVARK THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.